Insights from 2024 SGO Annual Meeting


 

SGO 2024 Insights: "The Use of Rucaparib vs. Placebo Maintenance Therapy in Metastatic & Recurrent Endometrial Cancer"

226 views
March 29, 2024
0 Comments
Login to view comments. Click here to Login
Videos